Skip to content

Evolus EOLS Change in fair value of contingent consideration

Change in fair value of contingent consideration at other companies

Limbach Holdings, Inc. logo
Limbach Holdings, Inc.LMB
$149K-65.1%
CareDx logo
CareDxCDNA
$0-100%
Pacific Biosciences of California logo
Pacific Biosciences of CaliforniaPACB
$0+100%
Commvault Systems logo
Commvault SystemsCVLT
$0
Playtika Holding Corp. logo
Playtika Holding Corp.PLTK
$95M+1,277%
IAR
Integra LifeSciencesIART
-$1.29M-698%

Other financials

Income statement

See full
Revenue$73.1M+6.7%
Gross profit$48.9M+4.8%
Operating income-$6.8M+54.9%
Net income-$10.7M+43.5%
EPS (diluted)-$0.16+46.7%

Balance sheet

See full
Cash & equivalents$49.8M-26.7%
Total debt$164.9M-4.1%
Total equity-$28.8M-336%
Total assets$220.6M+3.4%

Cash flow

See full
Operating cash flow-$10.0M+36.3%
CapEx$415.0K+30.1%
Free cash flow-$10.4M+35.0%

Valuation

See full
Market cap$470.86M-21.3%
Enterprise value$585.97M-16.6%
P/S1.6×-0.6×

Profitability

See full
Gross margin66.1%-2.4pp
Operating margin-13.7%-1.9pp
Net margin-14.4%-3.3pp
FCF margin-9.6%-3.6pp

Returns & leverage

See full
Return on equity-472.6%-1,534pp
Debt / equity22.2×
Current ratio-0.3×

Where this comes from

Reported directly by Evolus in its filing.

Tagged under the XBRL concept us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1.

The official record: Evolus’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Evolus's change in fair value of contingent consideration.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Evolus's change in fair value of contingent consideration?
Evolus (EOLS) reported change in fair value of contingent consideration of -$14K in Q1 2026.
How has Evolus's change in fair value of contingent consideration changed year-over-year?
Evolus's change in fair value of contingent consideration decreased by 100.7% year-over-year, from $2.15M to -$14K.
What is the long-term trend for Evolus's change in fair value of contingent consideration?
Over 3 years (2021 to 2025), Evolus's change in fair value of contingent consideration has grown at a 0.5% compound annual growth rate (CAGR), from $6.29M to -$6.38M.
What does change in fair value of contingent consideration mean?
This represents the non-cash adjustment to the fair value of liabilities related to acquisition-based earn-outs or contingent payment obligations. Changes in this value reflect updates to management's expectations regarding the achievement of future performance milestones or financial targets. It is a critical indicator of the evolving cost of past business combinations.